Abstract
Objective: We found a novel marine drug, SZ–685C, that was isolated from the secondary metabolites of a mangrove endophytic fungus (No. 1403) collected from the South China Sea, which has been reported to inhibit the proliferation of certain tumor cells. However, its anticancer mechanism remains unknown. The aims of this study were to observe the effectiveness of SZ–685C on pituitary adenoma cells and determine the underlying mechanisms of action.
Methods: A rat prolactinoma cell line, MMQ, was used in this study. A dose escalation of SZ–685C was performed on this cell line, and cell viability was assessed using an MTT assay. Hoechst 33342, Annexin V–FITC/PI, TUNEL staining and flow cytometry were used to evaluate the extent of apoptosis at each concentration of SZ–685C. The effect of SZ–685C on prolactin expression was also evaluated using RT–PCR and immunoblotting. Quantitative RT–PCR was used to detect the expression of miR–200c in SZ–685C–stimulated MMQ cells and pituitary adenoma tissues. This miRNA was then overexpressed in MMQ cells via transfection of a miR–200c mimic to identify the mechanism underling the anti–tumor effect of SZ–685C.
Results: SZ–685C inhibited MMQ cell growth in a dose–dependent manner but showed little toxicity toward rat pituitary cells (RPCs). The IC50s of SZ–685C in MMQ cells and RPCs were 13.2 ± 1.3 mM and 49.1 ± 11.5 mM, respectively, which was statistically significant. Increasing numbers of apoptotic cells were observed in response to escalating concentrations of SZ–685C, and the expression level of prolactin (PRL) was inhibited. Nevertheless, the level of PRL mRNA was unchanged. Additionally, miR–200c was upregulated in MMQ cells compared with RPCs, and downregulation of miR– 200c was observed in SZ–685C–treated MMQ cells. Furthermore, the overexpression of miR–200c weakened the effect of SZ–685C–induced apoptosis of MMQ cells.
Conclusions: Our results suggest that SZ–685C induces MMQ cell apoptosis in a miR–200c–dependent manner. Therefore, SZ–685C might be a useful alternative treatment for pituitary adenoma.
Keywords: Pituitary adenoma, marine drug, SZ–685C, apoptosis, microRNA, miR–200c, prolactinoma, MMQ cell, mangrove endophytic fungus, treatment
Current Medicinal Chemistry
Title:A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Volume: 20 Issue: 16
Author(s): C.–H. Chen, W.–W. Xiao, X.–B. Jiang, J.–W. Wang, Z.–G. Mao, N. Lei, X. Fan, B.–B. Song, C.–X. Liao, H.–J. Wang, Z.–G. She and Y.–H. Zhu
Affiliation:
Keywords: Pituitary adenoma, marine drug, SZ–685C, apoptosis, microRNA, miR–200c, prolactinoma, MMQ cell, mangrove endophytic fungus, treatment
Abstract: Objective: We found a novel marine drug, SZ–685C, that was isolated from the secondary metabolites of a mangrove endophytic fungus (No. 1403) collected from the South China Sea, which has been reported to inhibit the proliferation of certain tumor cells. However, its anticancer mechanism remains unknown. The aims of this study were to observe the effectiveness of SZ–685C on pituitary adenoma cells and determine the underlying mechanisms of action.
Methods: A rat prolactinoma cell line, MMQ, was used in this study. A dose escalation of SZ–685C was performed on this cell line, and cell viability was assessed using an MTT assay. Hoechst 33342, Annexin V–FITC/PI, TUNEL staining and flow cytometry were used to evaluate the extent of apoptosis at each concentration of SZ–685C. The effect of SZ–685C on prolactin expression was also evaluated using RT–PCR and immunoblotting. Quantitative RT–PCR was used to detect the expression of miR–200c in SZ–685C–stimulated MMQ cells and pituitary adenoma tissues. This miRNA was then overexpressed in MMQ cells via transfection of a miR–200c mimic to identify the mechanism underling the anti–tumor effect of SZ–685C.
Results: SZ–685C inhibited MMQ cell growth in a dose–dependent manner but showed little toxicity toward rat pituitary cells (RPCs). The IC50s of SZ–685C in MMQ cells and RPCs were 13.2 ± 1.3 mM and 49.1 ± 11.5 mM, respectively, which was statistically significant. Increasing numbers of apoptotic cells were observed in response to escalating concentrations of SZ–685C, and the expression level of prolactin (PRL) was inhibited. Nevertheless, the level of PRL mRNA was unchanged. Additionally, miR–200c was upregulated in MMQ cells compared with RPCs, and downregulation of miR– 200c was observed in SZ–685C–treated MMQ cells. Furthermore, the overexpression of miR–200c weakened the effect of SZ–685C–induced apoptosis of MMQ cells.
Conclusions: Our results suggest that SZ–685C induces MMQ cell apoptosis in a miR–200c–dependent manner. Therefore, SZ–685C might be a useful alternative treatment for pituitary adenoma.
Export Options
About this article
Cite this article as:
Chen C.–H., Xiao W.–W., Jiang X.–B., Wang J.–W., Mao Z.–G., Lei N., Fan X., Song B.–B., Liao C.–X., Wang H.–J., She Z.–G. and Zhu Y.–H., A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c, Current Medicinal Chemistry 2013; 20 (16) . https://dx.doi.org/10.2174/0929867311320160007
DOI https://dx.doi.org/10.2174/0929867311320160007 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Endometriosis and Gynecological Cancer
Current Women`s Health Reviews The Therapeutic Potential of ADAM15
Current Pharmaceutical Design Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population
Current Genomics Comprehensive Review of Cancer Chemopreventive Agents Evaluated in Experimental Carcinogenesis Models and Clinical Trials
Current Medicinal Chemistry Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia
Current Pharmacogenomics Cytosine Methyltransferases as Tumor Markers
Current Genomics Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling
Current Medicinal Chemistry Functions of S100 Proteins
Current Molecular Medicine Modulation of Porcine (Sus scrofa domestica) and Pheasant (Phasianus colchicus) Carbonyl Reducing Enzymes by Anthelmintic Therapy with Flubendazole
Drug Metabolism Letters Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology Chemistry of Plant Dyes: Applications and Environmental Implications of Dyeing Processes
Current Environmental Engineering Recent Progress in the Development of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Carcinogenicity and Chronic Rodent Toxicity of the Selective Progesterone Receptor Modulator Ulipristal Acetate
Current Drug Safety Towards Second Generation Hypericin Based Photosensitizers for Photodynamic Therapy
Current Organic Chemistry Functional Role of miR-34 Family in Human Cancer
Current Drug Targets Anti-cancer and Anti-angiogenic Properties of Various Natural Pentacyclic Tri-terpenoids and Some of their Chemical Derivatives
Current Organic Chemistry BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
Current Cancer Drug Targets TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Current Pharmaceutical Biotechnology